- Home
- ERAS vs EVGO Comparison
ERAS vs EVGO Comparison
Compare ERAS & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- EVGO
- Stock Information
- Founded
- ERAS 2018
- EVGO 2010
- Country
- ERAS United States
- EVGO United States
- Employees
- ERAS 129
- EVGO N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- EVGO Other Specialty Stores
- Sector
- ERAS Health Care
- EVGO Consumer Discretionary
- Exchange
- ERAS Nasdaq
- EVGO Nasdaq
- Market Cap
- ERAS 413.6M
- EVGO 376.5M
- IPO Year
- ERAS 2021
- EVGO N/A
- Fundamental
- Price
- ERAS $1.42
- EVGO $3.49
- Analyst Decision
- ERAS Strong Buy
- EVGO Buy
- Analyst Count
- ERAS 6
- EVGO 9
- Target Price
- ERAS $4.83
- EVGO $6.13
- AVG Volume (30 Days)
- ERAS 1.1M
- EVGO 4.6M
- Earning Date
- ERAS 08-11-2025
- EVGO 07-31-2025
- Dividend Yield
- ERAS N/A
- EVGO N/A
- EPS Growth
- ERAS N/A
- EVGO N/A
- EPS
- ERAS N/A
- EVGO N/A
- Revenue
- ERAS N/A
- EVGO $276,954,000.00
- Revenue This Year
- ERAS N/A
- EVGO $40.85
- Revenue Next Year
- ERAS N/A
- EVGO $32.70
- P/E Ratio
- ERAS N/A
- EVGO N/A
- Revenue Growth
- ERAS N/A
- EVGO 45.15
- 52 Week Low
- ERAS $1.01
- EVGO $2.20
- 52 Week High
- ERAS $3.45
- EVGO $9.07
- Technical
- Relative Strength Index (RSI)
- ERAS 53.15
- EVGO 46.55
- Support Level
- ERAS $1.42
- EVGO $3.37
- Resistance Level
- ERAS $1.58
- EVGO $3.60
- Average True Range (ATR)
- ERAS 0.10
- EVGO 0.20
- MACD
- ERAS 0.01
- EVGO -0.03
- Stochastic Oscillator
- ERAS 68.65
- EVGO 38.08
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.